Which works better for urinary incontinence — conservative treatment or surgery? For mild-to-moderate stress incontinence, supervised pelvic floor training helps most women and cures a majority in trials, with almost no risk. Surgery, especially the midurethral sling, produces higher and more durable cure rates — reported success generally 80–90%, with roughly 77% or more of women cured or significantly improved — and is the stronger choice when leakage is severe or conservative care hasn't been enough. Minimally invasive options such as PDO threads combined with PRP injections sit between these two, as a genuine but less-proven middle option for carefully selected candidates. The best-supported plan starts conservative and escalates only if symptoms remain bothersome.
📚 Articles in This Cluster
Why This Comparison Matters
Most women who come to us with leaking urine arrive already holding an opinion. Some are convinced exercises are a waste of time and want "the operation that fixes it." Others are wary of surgery — often because of mesh stories they've read online — and want anything but a procedure. Both groups deserve a straight answer, not a sales pitch.
This article lays the conservative and surgical evidence side by side, honestly, so you can see what each approach actually delivers — and where a newer, minimally invasive option like PDO+PRP thread therapy genuinely fits, without overstating what it's proven to do.
Curious where you'd fall on the pathway? See our Treatment Guide for the full options →
Quick Overview: Conservative vs. Surgical, in Plain Terms
For mild-to-moderate stress incontinence, supervised pelvic floor training helps most women and cures a majority in trials, with almost no risk. Surgery — especially the midurethral sling — produces higher and more durable cure rates and is the stronger choice when leakage is severe or conservative care hasn't been enough. The best-supported plan starts conservative and escalates to surgery only if symptoms remain bothersome.
What We're Actually Comparing
Conservative (non-surgical) treatment includes supervised pelvic floor muscle training (PFMT), bladder training and timed voiding, lifestyle change (weight loss, treating chronic cough, managing constipation), support pessaries, and adjunctive clinic technologies such as electromagnetic chair therapy, laser, or radiofrequency, which sit between "pure conservative" and "procedural."
Surgical treatment covers midurethral synthetic slings (retropubic and transobturator), single-incision mini-slings, autologous fascial slings (using your own tissue instead of mesh), Burch colposuspension, and urethral bulking injections.
Most of the strongest comparative evidence concerns stress urinary incontinence; urge and mixed incontinence follow different rules.
How Researchers Measure "Success"
Here's the part almost no clinic explains, and it's the reason two honest sources can quote very different cure rates for the same operation. Studies report two kinds of cure: objective cure means a test (a cough stress test or pad-weight test) shows no leakage; subjective cure means the woman herself says she's dry or no longer bothered. These don't move together — in the landmark TOMUS trial comparing sling types, objective success sat around 77–81% at one year, while subjective success was only 56–62%.
Time changes the picture too. A recent long-term review found objective continence after retropubic slings stayed stable above 85–90% past 10 years, yet patient-reported satisfaction slowly declined — mostly because of new overactive-bladder symptoms developing over the years, not because the sling "failed."
The Evidence for Conservative Treatment
Pelvic floor muscle training is not folk advice — it's Level 1, Grade A evidence. A widely cited Cochrane analysis found that women with stress incontinence who did supervised PFMT were far more likely to report a cure than untreated women: 56% versus 6% across the highest-quality trials, with no adverse effects. Short-term cure rates, defined strictly as under 2g of leakage on pad testing, range from 35% to 80% depending on how intensively the program is delivered — supervised, higher-intensity training beats unsupervised home exercise almost every time.
Where conservative care falls short is honesty about durability and ceiling: benefits fade if you stop practicing, and it rarely produces complete dryness in severe stress incontinence or significant anatomical weakness.
The Evidence for Surgical Treatment
On raw effectiveness, surgery wins — the midurethral sling is the most thoroughly studied continence operation in history, backed by extensive Level 1 evidence. Reported therapeutic success ranges from 80% to 90%. A Cochrane review of 55 randomized trials found short-term subjective cure of 71–97% for retropubic and 62–98% for transobturator slings; at five years, both settled into the 43–92% range. The longest follow-up on record — 17 years — reported durable results with no late adverse events.
Not all slings are equal: the retropubic route achieves higher cure than the transobturator route in large comparative data, though it carries a slightly higher rate of intraoperative bladder injury. For women who prefer to avoid mesh entirely, autologous fascial slings — using your own tissue — match sling cure rates with negligible long-term mesh risk, at the cost of longer surgery and more short-term voiding difficulty.
The honest caveats: surgery means anaesthesia, recovery time, and real if uncommon risks — bladder injury, temporary retention, de novo urgency, and, with mesh, exposure. Mesh reintervention runs about 2–3% at eight years in large cohorts.
Wondering whether you're even a surgical candidate? A proper assessment answers that in one visit. Dr. Dina Rezk does not perform sling surgery in-house — every plan starts with the least invasive option that fits your case, and appropriate candidates are referred to a trusted surgical colleague.
Where PDO+PRP Thread Therapy Fits
Between conservative therapy and surgery sits a growing category of minimally invasive, office-based options. At Dr. Dina Rezk Clinic, the option used in the great majority of our appropriate cases is PDO smart threads combined with PRP injections. We think it's important to place this honestly on the evidence spectrum, rather than either ignoring it or overstating it.
The strongest evidence directly testing PDO threads combined with PRP comes from a small pilot study (Luksenburg et al., 2022) — encouraging but preliminary. A separate, frequently cited 99.2% cure figure (Tomadze, Sulamanidze & Tsivtsivadze, 2022, 124 women, 3-year follow-up) is real and well-documented, but it tested the APTOS thread technique used alone, without PRP — a different procedure — and should not be read as direct evidence for the combined PDO+PRP approach. Neither of these studies is comparable in size, design, or follow-up length to the sling literature above (which spans dozens of randomized trials and cohorts with thousands of patients over up to 17 years).
Our honest position: PDO+PRP is a reasonable, minimally invasive option for appropriately selected mild-to-moderate stress incontinence, particularly for women who want to avoid surgery and have not had full relief from pelvic floor therapy alone. It is not established as equivalent to, or superior to, surgical sling — the evidence base simply isn't there yet — and we do not rank it above surgery in comparison tables. It is a genuine "in-between" option, not a replacement for either end of the pathway.
Head to Head: How the Outcomes Compare
| Dimension | Conservative (Supervised PFMT) | PDO+PRP Threads (Minimally Invasive) | Surgical (Midurethral/Fascial Sling) |
|---|---|---|---|
| Reported cure (stress incontinence) | ~56% cure vs 6% untreated in trials; 35–80% on strict pad testing | Promising in a small pilot study; not yet established in large trials | 80–90% success; RMUS ~89%, fascial ~89% in network meta-analysis |
| Evidence base | Level 1, multiple large RCTs and Cochrane reviews | One small pilot study for the PRP+PDO combination | Extensive — dozens of RCTs, cohorts to 17 years, thousands of patients |
| Durability | Fades if exercises stop | Threads absorb over several months; long-term durability not yet well studied | Objective continence stable >85–90% past 10 years |
| Main risks | Essentially none beyond transient soreness | Minor procedural risks; office-based, local anesthesia | Anaesthesia, bladder injury, retention, de novo urgency; mesh reintervention ~2–3% at 8 yrs |
| Recovery | No downtime | 1–3 days | Days to weeks |
| Guideline role | First-line | Selected, minimally invasive option; not yet in major society guidelines | Established second-line / definitive option |
Research Highlights
| Study / Source | Year | Design | Main Findings | Evidence Level |
|---|---|---|---|---|
| Cochrane PFMT review (via AAFP summary) | 2020 | Systematic review of RCTs | Cure 56% PFMT vs 6% control; no harms | ★★★★★ |
| ESTER systematic review ("25 Years of MUS") | 2022 | Network meta-analysis, 175 studies | RMUS ~89%, fascial ~89%, TMUS ~64%, PFMT alone ~3% "cure" in this network | ★★★★★ |
| 10-year MUS cohort | 2023 | Prospective cohort, >2,400 women | Subjective cure 63.3%, improvement ~80% at 10 yrs; retropubic > transobturator | ★★★☆☆ |
| TOMUS trial | 2010 | Multicenter RCT, 597 women | Objective success RMUS 80.8% vs TMUS 77.7% (equivalent) | ★★★★☆ |
| PRP + PDO thread pilot study (Luksenburg et al.) | 2022 | Pilot study | Early evidence of periurethral tissue support with combined PRP+PDO placement | ★★☆☆☆ (preliminary) |
| APTOS thread method, no PRP (Tomadze et al.) | 2022 | Prospective cohort, 124 women, 3-yr follow-up | 99.2% cure reported for threads alone; not evidence for the PRP-combined technique | ★★★☆☆ (single technique, single center) |
The Stepwise Pathway Most Guidelines Recommend
- Assess and diagnose: history, pelvic exam, bladder diary, checking for prolapse, urodynamics in complex cases.
- Start conservative: supervised PFMT, lifestyle optimization, weight management.
- Re-evaluate after ~3 months: review symptom change and your own goals.
- Consider escalation if still bothered: discuss minimally invasive options like PDO+PRP for appropriate candidates, or sling type/fascial options by surgical referral, based on your anatomy, severity, and preference.
What This Means for Women in Riyadh
The evidence is global, but the decision is personal — and here, culturally specific. In clinic, the leaks that distress women most aren't always the biggest ones; they're the ones tied to daily prayer, to wudu, to keeping an abaya spotless in the heat. Riyadh women have real access to the full pathway — supervised pelvic floor physiotherapy, our in-clinic PDO+PRP option, and, by referral, experienced urogynecologic surgery — so a plan can genuinely start conservative and escalate without leaving the city.
Myths vs. Facts
Myth: Surgery is the only thing that actually works.
Fact: Supervised pelvic floor training cures a majority of women with mild-to-moderate stress incontinence in trials, with no adverse effects.
Myth: Kegels are useless — everyone ends up needing an operation.
Fact: Roughly 56% cure versus 6% untreated is not useless. Adherence and correct technique separate success from failure.
Myth: PDO+PRP threads have been proven to beat surgery.
Fact: The evidence for PDO+PRP together comes from a small pilot study. Surgery has decades of much larger trials behind it. We treat PDO+PRP as a genuine minimally invasive option for appropriate candidates — not as a replacement for, or superior alternative to, surgical sling.
Myth: Mesh means you'll definitely have complications.
Fact: Mesh reintervention runs about 2–3% at eight years, and mesh-free fascial slings exist for women who prefer to avoid it entirely.
Myth: A cure is a cure — the percentages online all mean the same thing.
Fact: Objective (test-based) and subjective (patient-reported) cure differ by 15–20 points in the same trials. Always check which one a number refers to.
Clinical Perspective from Dr. Dina Rezk
The following reflects clinical experience and is offered alongside — not in place of — the published evidence above.
What the trials can't capture is how differently two women with the "same" leakage feel about it. I've had patients with mild stress incontinence who wanted a solution immediately because the leaks affected their confidence, and patients with fairly heavy leakage who were happy to keep managing conservatively for years. Neither is wrong — my job is to make sure the choice is informed, not rushed. What I do see cause regret is skipping the assessment step: treating a mixed or urgency problem as if it were pure stress incontinence, and being disappointed when a treatment doesn't fix a symptom it was never meant to fix.
🚨 Red Flags: When to Seek Care Sooner
A conservative-versus-surgical decision should never delay urgent evaluation. Get medical attention promptly for:
- Blood in the urine unrelated to your period
- Sudden inability to pass urine, or severe pelvic pain
- Fever, flank or back pain, or a suspected kidney infection
- New leg weakness, numbness in the saddle area, or loss of bowel control
Frequently Asked Questions
What has a higher success rate — pelvic floor exercises or surgery for incontinence?
Surgery has the higher cure rate. Midurethral and fascial slings reach roughly 80-90% success, while supervised pelvic floor training cures about 56% of women with stress incontinence in trials. Exercises carry almost no risk, so guidelines still recommend trying them first.
How long should I try pelvic floor exercises before considering surgery?
Most studies use about three months of supervised, correctly performed training as a fair trial, followed by reassessment. Some women continue longer while still improving; others move to surgery sooner if leakage is severe and clearly limiting despite good effort.
What is the success rate of the sling operation?
Reported success is generally 80-90%, and objective continence stays above 85-90% past ten years in retropubic sling cohorts, with roughly 77% or more of women cured or significantly improved depending on the study.
Is incontinence surgery permanent?
Sling results are durable — the longest follow-up runs 17 years — but permanent is not guaranteed. A small proportion of women develop recurrent leakage or new bladder symptoms over the years and may need further treatment.
Where does PDO+PRP thread therapy fit compared to exercises and surgery?
PDO threads combined with PRP injections sit as a minimally invasive option between conservative therapy and surgery for appropriately selected stress incontinence cases. The evidence for this specific combination is still limited to a small pilot study, so it should not be assumed to match or exceed the cure rates established for surgery in much larger trials.
The Bottom Line
If leaking urine is shaping your day, you have more good options than the internet's two loudest camps suggest. The evidence is genuinely reassuring: most women improve with low-risk conservative care, a minimally invasive option like PDO+PRP is a reasonable middle step for the right candidate, and for those who need more, surgery offers high, lasting cure rates. This isn't a choice between giving up and going under the knife — it's a pathway, and you get to move through it at your pace, starting with a clear diagnosis.
Book a confidential consultation with Dr. Dina Rezk in Riyadh to map your personal pathway — least invasive first, escalating only if and when you're ready.
Written by the Dr. Dina Rezk Clinic editorial team, based on clinical guidelines from NICE, EAU, and AUA/SUFU and on systematic reviews in Cochrane, the International Urogynecology Journal, and NEJM. This article is educational and does not replace a personal medical consultation.
References
- American Academy of Family Physicians (summarizing Cochrane review on pelvic floor muscle training). Am Fam Physician. 2020.
- Bø K, et al. Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction. 2012.
- Twenty-Five Years of the Midurethral Sling: Lessons Learned (incl. ESTER network meta-analysis of 175 studies). Int Neurourol J. 2022.
- Ten-year outcomes of midurethral slings; retropubic vs transobturator. Int Urogynecol J. 2023.
- Richter HE, et al. Retropubic versus Transobturator Midurethral Slings for Stress Incontinence (TOMUS). N Engl J Med. 2010.
- American Urological Association / SUFU. Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline (2017, amended 2023).
- European Association of Urology. Guidelines on Surgical Treatment of Urinary Incontinence.
- Tomadze T, Sulamanidze M, Tsivtsivadze M. The Use of the Minimally Invasive APTOS Thread Method for the Treatment of Female Stress Urinary Incontinence: 3-year Follow-up Results. Ann Minim Invasive Surg. 2022;4(1):67–71.
- Luksenburg A, Barcia JJ, Sergio R, et al. Stress Urinary Incontinence: Treatment With Platelet-Rich-Plasma Injection and Placement of Polydioxanone Threads — A Pilot Study. The American Journal of Cosmetic Surgery. 2022;39(1):76–84.